[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353450-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353450-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","alkaline-loading-of-extracellular-vesicles-produced-from-human-neural-stem-cell-derived-neurospheres-enables-cns-drug-delivery","Alkaline loading of extracellular vesicles produced from human neural stem cell-derived neurospheres enables CNS drug delivery","","The blood–brain barrier and blood tumor barrier restrict therapeutic delivery to the central nervous system, making CNS drug delivery a persistent challenge. Extracellular vesicles (EVs) have emerged as a promising vehicle because they can penetrate BBB/BTB and show lower immunogenicity than liposomal carriers. Using a human neural stem cell suspension neurosphere system, the work develops an alkaline passive loading approach for producing EVs. Doxorubicin-loaded hNSC-EVs induce glioma cytotoxicity in vitro and improve BBB penetrance in vivo, supporting EV-based treatment potential for brain cancers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/alkaline-loading-of-extracellular-vesicles-produced-from-human-neural-stem-cell-derived-neurospheres-enables-cns-drug-delivery/353450/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/alkaline-loading-of-extracellular-vesicles-produced-from-human-neural-stem-cell-derived-neurospheres-enables-cns-drug-delivery/353450.png","ImageObject",300,407,{"name":42,"@type":43},"pixelkiddo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main challenge addressed in this study?","Question",{"text":63,"@type":64},"Delivering drugs to the central nervous system is difficult due to the restrictive blood–brain barrier and blood tumor barrier.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why are extracellular vesicles considered useful for CNS drug delivery?",{"text":68,"@type":64},"EVs can penetrate BBB/BTB and are less immunogenic than liposomal carriers, enabling transport of cargo such as small molecules, RNA, and proteins.",{"name":70,"@type":61,"acceptedAnswer":71},"What cargo and loading method were used as the proof of concept?",{"text":72,"@type":64},"Doxorubicin was loaded into hNSC-derived EVs using a novel, high-efficiency alkaline passive loading method.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353450,1790126698,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":55,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nAlkaline loading of extracellular vesicles produced from human neural stem cell-derived neurospheres enables CNS drug delivery  \nAmar M. Singh1􀀍, Charles M. White2, Adeline Phillips2, Logan P. Crowe2, Robert Marti2, Morgan C. Finnerty3, Martonio Ponte Viana2, William Antoniades2, Michael G. Bartlett3, Viviana Martinez2, Raymond Swetenburg2 & Steven L. Stice1,2􀀍  \nThe blood brain barrier and blood tumor barrier (BBB and BTB, respectively) represent significant obstacles for the delivery of drugs to treat diseases of the central nervous system, such as brain cancersand neurodegenerative diseases. Extracellular vesicles (EVs) or exosomes have emerged as a new drug delivery vehicle for CNS diseases as they may penetrate the BBB/BTB and are less immunogenic than liposomal carriers. EVs derived from human neural stem cells (hNSC) provide additional benefits over other EV sources due to their increased homing capability to neural cells and demonstrated efficacy for treating stroke and traumatic brain injury in rodent models. However, the utilization of EVs from hNSC for drug delivery remains largely unexplored, due in part to difficulties in manufacturing capacity compared to traditional cell lines. Here, we report the development of a hNSC suspension neurosphere system for EV production and drug delivery. As proof of concept, doxorubicin was loaded into hNSC-EV, using a novel, high-efficiency alkaline passive loading method, and shown to be effective at inducing cytotoxicity in glioma cells in vitro and exhibiting higher BBB penetrance than doxorubicin-alone in vivo. These studies demonstrate the potential for hNSC-EV loaded doxorubicin asa therapeutic treatment for brain cancers such as glioblastoma, while also establishing hNSC-EVs as a drug-delivery vehicle for CNS diseases.  \nKeywords Extracellular vesicles, Exosomes, Doxorubicin, Neural stem cells, Neural progenitor cells, Blood– brain barrier, Glioblastoma, Drug delivery, Alkaline loading  \nThe blood–brain barrier (BBB) serves a critical function in protecting the brain and spinal cord from toxins and other chemical insults, while maintaining the necessary homeostatic balance to maintain oxygen and nutrient levels1. However, due to this strict control between the vasculature and the central nervous system (CNS), the delivery of therapeutics to treat CNS diseases is severely hampered2. Furthermore, upon the development of a primary brain tumor or brain metastasis from a non-CNS tumor, a blood-tumor barrier (BTB) is established. Unlike the BBB, the BTB is heterogeneous and often “leaky” due to the lack of tight junctions and reduced supporting cells3. However, similarly to the BBB, the BTB serves a restrictive role in preventing the delivery of therapeutics at optimal concentrations, which could otherwise be used to treat and prevent further tumor progression4.  \nOver the past decade, multiple approaches, including receptor-mediated transcytosis, nanoparticles and extracellular vesicles (EVs), have been evaluated to enable the delivery of drugs through the BBB/BTB to the CNS with varying levels of success2,5. The method that has been most intensely investigated is the use of the Transferrin receptor (TfR), which relies on receptor-mediated transcytosis to transport a cargo through the BBB5. Several caveats to this approach exist however, such as lack of brain specificity6, TfR recycling partially  \n1Regenerative Bioscience Center, Rhodes Center for Animal and Dairy Science, University of Georgia, Athens, GA 30602, USA. 2Aruna Bio, Inc., Athens, GA 30602, USA. 3Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602, USA. 􀀍 email: [singha@uga.edu](singha@uga.edu); [sstice@arunabio.com](sstice@arunabio.com)  \npreventing exocytosis in the brain7,8, and lysosomal degradation9. Several other receptors are still being evaluated, with most still in ","cbCaiu9FqAZqSvEC","https://ap.wps.com/l/cbCaiu9FqAZqSvEC","pdf",2801496,"English","# Background\n## Barriers to CNS drug delivery\n## EVs as a drug delivery vehicle\n# EV loading and production approach\n## Donor cell choice for CNS relevance\n## Alkaline passive loading of hNSC-EVs\n# Results and therapeutic implications","[{\"question\":\"What is the main challenge addressed in this study?\",\"answer\":\"Delivering drugs to the central nervous system is difficult due to the restrictive blood–brain barrier and blood tumor barrier.\"},{\"question\":\"Why are extracellular vesicles considered useful for CNS drug delivery?\",\"answer\":\"EVs can penetrate BBB/BTB and are less immunogenic than liposomal carriers, enabling transport of cargo such as small molecules, RNA, and proteins.\"},{\"question\":\"What cargo and loading method were used as the proof of concept?\",\"answer\":\"Doxorubicin was loaded into hNSC-derived EVs using a novel, high-efficiency alkaline passive loading method.\"}]","Alkaline loading of extracellular vesicles produced from human neural stem cell-derived neurospheres enables CNS drug delivery | PDF",1790105493,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cf9b7565142841169e2d75cefe2b5b9.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb00c1ec5ec357a98b402b1ef5246dae.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5dca3b774186d0540e1300c25a29d6c.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb842c479971126a111afc49d5f70c9f.webp",980,1287]